Isovaleric Acidemia
An inherited organic acidemia caused by IVD gene variants that impair leucine breakdown, leading to toxic buildup of isovaleric acid and risk of life-threatening metabolic crises.
- IVD Gene-Related
- Often Found on Newborn Screening
- Managed with Diet, Carnitine & Glycine
- Better Outcomes with Early Diagnosis
- Gene Involved
- IVD
- Inheritance Pattern
- Autosomal Recessive
- Typical Onset
- Neonatal or Early Childhood
- Core Management
- Diet, Carnitine, Glycine
- Specialist Support
- Metabolic Crisis Care Access
Condition Overview
Isovaleric Acidemia (IVA) is an inherited organic acid disorder caused by variants in the IVD gene, which encodes the enzyme isovaleryl-CoA dehydrogenase. This enzyme is needed to break down leucine, one of the branched-chain amino acids obtained from dietary protein. When the enzyme is deficient, toxic intermediates such as isovaleric acid accumulate, which can cause a distinctive odor (often described as resembling sweaty feet), metabolic acidosis, and, in severe cases, life-threatening crises.
IVA is now frequently identified through expanded newborn screening, allowing treatment to begin before a severe metabolic crisis occurs. Management centers on a leucine-restricted diet, supplementation with carnitine and glycine, and a clear emergency plan for illness or fasting, which can trigger metabolic decompensation.
Forms and Presentation
Isovaleric Acidemia is generally described by the timing and severity of its first presentation.
Symptoms and Signs
Symptoms of IVA range from subtle feeding difficulties to severe, life-threatening metabolic crises, often triggered by illness, fasting, or high protein intake.
Causes and Risk Factors
Isovaleric Acidemia is caused by inherited variants that impair the breakdown of leucine, an essential branched-chain amino acid.
Diagnosis and Investigations
Diagnosis combines newborn screening or acute biochemical testing with genetic confirmation, particularly important given the risk of rapid deterioration during crises.
Severity Classification
IVA severity is generally categorized by age and pattern of presentation rather than a formal staging system, which helps guide the intensity of ongoing management.
Standard Management
Management of IVA combines long-term dietary leucine restriction and supplementation with a structured emergency protocol to prevent and treat metabolic crises.
Specialized & Emerging Management Approaches
Beyond standard dietary and supplement therapy, specialized metabolic centers provide structured crisis management protocols, and research continues into refining long-term care.
Nutritional Therapy
Leucine-Restricted Medical Formula
Specialized medical foods support growth while limiting leucine intake to reduce toxic metabolite production.
Pharmacologic Therapy
L-Carnitine and Glycine Supplementation
Helps detoxify isovaleryl-CoA by forming excretable conjugates, reducing the burden of toxic metabolites.
Emergency Care Protocols
Individualized Sick-Day / Emergency Management Plans
Structured protocols developed with metabolic specialists to guide families and emergency teams during illness or fasting.
Emerging Research
Gene and Enzyme-Based Research
Early-stage research into gene-based or enzyme-targeted approaches for organic acidemias is ongoing, though not yet part of routine IVA care.
Relevant Laboratory Markers
Biochemical markers are essential both for confirming the diagnosis and for monitoring metabolic control over time.
When to Seek a Specialist Second Opinion
A specialist second opinion can be valuable for refining dietary management, addressing recurrent crises, or providing reassurance during family planning.
Research and Clinical Studies
Outlook and Long-Term Management
With early diagnosis, often through newborn screening, and consistent dietary and emergency management, many individuals with IVA achieve good growth and development with a reduced risk of severe metabolic crises.
Supportive Care and Daily Living
Living with IVA involves coordinated nutritional management, illness preparedness, and ongoing developmental support.
How CancerFax Helps You Explore Treatment Options
CancerFax can help you get specialist review of newborn screening or metabolic test results related to Isovaleric Acidemia and connect you with experienced metabolic disease specialists.
Get a free case reviewFrequently Asked Questions
It is an inherited organic acid disorder caused by IVD gene variants that impair leucine breakdown, leading to toxic buildup of isovaleric acid and related compounds.
Poor feeding, vomiting, lethargy, and a distinctive odor resembling sweaty feet are common early signs, often appearing in the first days to weeks of life.
Diagnosis often begins with newborn screening, followed by confirmatory plasma acylcarnitine, urine organic acid, and genetic testing.
Treatment includes a leucine-restricted diet, carnitine and glycine supplementation, and a structured emergency plan for illness or fasting.
There is no cure, but consistent dietary management and prompt treatment of illness episodes can substantially reduce the risk of serious complications.
Infections increase the breakdown of body protein, releasing more leucine than the impaired pathway can safely process, which can trigger a metabolic crisis.
It can, particularly if diagnosis is delayed or crises are severe, which is why early identification and consistent management are important.
Expanded newborn screening using tandem mass spectrometry is effective at identifying many cases of IVA before symptoms develop.
Yes, siblings of an affected child are often advised to undergo testing, since the recurrence risk in future pregnancies is significant for autosomal recessive conditions.
Yes. CancerFax can help you submit newborn screening and metabolic reports for specialist review, request a second opinion on diagnosis or management, and connect with metabolic disease specialists internationally.
Get Expert Guidance on Isovaleric Acidemia
Send your newborn screening or metabolic reports for specialist review and connect with metabolic disease experts to support your family's care plan.